Action of an HMG CoA reductase inhibitor, lovastatin, on apoptosis of untransformed and ts-SV40 transformed human smooth muscle cells derived from saphenous vein

Journal of Cardiovascular Pharmacology

Volumn 38, Issue 2, 2001, Pages 161-173

  Unlu, Sebnem ^a   Clunn, Gerard ^a   Schachter, M ^a   Demoliou Mason, Catherine ^a   Hughes, Alan D ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; HMG CoA reductase; Lovastatin; Proliferation; SV40; Vascular smooth muscle

Indexed keywords

FARNESYL DIPHOSPHATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVALONIC ACID; MEVINOLIN; PLATELET DERIVED GROWTH FACTOR BB; PYROPHOSPHATE;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; CELL CYCLE; CELL IMMORTALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NICK END LABELING; PRIORITY JOURNAL; SAPHENOUS VEIN; SIMIAN VIRUS 40; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

APOPTOSIS; CELL DIVISION; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOVASTATIN; MUSCLE, SMOOTH, VASCULAR; SAPHENOUS VEIN; SIMIAN VIRUS 40;

EID: 0034927965     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200108000-00001     Document Type: Article

References (41)

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
2. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
3. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)
4. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study
5. The role of isoprenoids in vascular smooth muscle: Potential benefits of statins unrelated to cholesterol lowering
6. Statins do more than just lower cholesterol
7. Protein lipidation in cell signaling
8. Pharmacological control of the mevalonate pathway: Effect on arterial smooth muscle cell proliferation
9. Atherosclerosis - An inflammatory disease
10. Apoptosis in human atherosclerosis and restenosis
11. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques
12. Relationship between mevalonate pathway and arterial myocyte proliferation: In vitro studies with inhibitors of HMG-CoA reductase
13. Inhibition of human vascular smooth muscle cell proliferation by lovastatin: The role of isoprenoid intermediates of cholesterol synthesis
14. Differential effects of lovastatin on mitogen induced calcium influx in human cultured vascular smooth muscle cells
15. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells) and may contribute to the accumulation of gruel and plaque instability
16. Cellular biology of human intimal hyperplastic stenosis
17. p53, p21 (WAF1/CIP1), and MDM2 involvement in the proliferation and apoptosis in an in vitro model of conditionally immortalized human vascular smooth muscle cells
18. Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis)
19. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
20. Effect of angiotensin II on the expression of the early growth response gene c-fos and DNA synthesis in human vascular smooth muscle cells
21. A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry
22. Myosin heavy-chain isoforms in adult and developing rabbit vascular smooth muscle
23. Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase
24. Quiescent SV40 virus transformed 3T3 cells in culture
25. Mevalonic acid products as mediators of cell proliferation in simian virus 40-transformed 3T3 cells
26. Platelet-derived growth factor induces apoptosis in vascular smooth muscle cells: Roles of the Bcl-2 family
27. kip1
28. Mevalonate deprivation impairs IGF-I/insulin signaling in human vascular smooth muscle cells
29. Human and porcine smooth muscle cells share similar proliferation dependence on the mevalonate pathway: Implication for in vivo interventions in the porcine model
30. 3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture
31. Proapoptotic effect of atorvastatin on stimulated rabbit smooth muscle cells
32. Inhibiting geranylgeranylation blocks growth and promotes apoptosis in pulmonary vascular smooth muscle cells
33. Susceptibility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availability
34. Human multidrug-resistant (MRP,p190) myeloid leukemia HL-60/ADR cells in vitro: Resistance to the mevalonate pathway inhibitor lovastatin
35. Lovastatin induces fibroblast apoptosis in vitro and in vivo. A possible therapy for fibroproliferative disorders
36. Enhancement of drug-induced apoptosis by antisense oligodeoxynucleotides targeted against Mdm2 and p21WAF1/CIP1
37. The induction of apoptosis by SV40 T antigen correlates with c-jun overexpression
38. p53/T-antigen complex disruption in T-antigen transformed NIH3T3 fibroblasts exposed to oxidative stress: Correlation with the appearance of a Fas/APO-1/CD95 dependent, caspase independent, necrotic pathway
39. Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton
40. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1
41. HMG CoA reductase inhibitor-induced myotoxicity: Pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture